VITROS HBeAg Assays

FDA Premarket Approval P090008 S023

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

DeviceVITROS HBeAg Assays
Generic NameAssay, Enzyme Linked Immunosorbent, Hepatitis C Virus
ApplicantROCHE DIAGNOSTICS CORP.9115 Hague Rd.indianapolis, IN 46250 PMA NumberP090008 Supplement NumberS023 Date Received09/30/2022 Decision Date01/24/2023 Reclassified Date 12/22/2021 Product Code MZO  Advisory Committee Microbiology Supplement Typereal-time Process Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No
Date Received2022-09-30
Decision Date2023-01-24
PMAP090008
SupplementS023
Product CodeMZO 
Advisory CommitteeMicrobiology
Supplement TypeReal-time Process
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination ProductNo
Applicant AddressROCHE DIAGNOSTICS CORP.
9115 Hague Rd.
indianapolis, IN 46250 PMA NumberP090008 Supplement NumberS023 Date Received09/30/2022 Decision Date01/24/2023 Reclassified Date 12/22/2021 Product Code MZO  Advisory Committee Microbiology Supplement Typereal-time Process Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No Combination ProductNo Approval Order Statement  
Approval For Revisions To The Package Insert To Include Information On Biotin Interference.

Supplemental Filings

Supplement NumberDateSupplement Type
P090008Original Filing
S023 2022-09-30 Real-time Process
S022
S021 2018-10-26 Normal 180 Day Track No User Fee
S020 2018-04-17 Real-time Process
S019 2017-10-11 Real-time Process
S018 2017-08-03 30-day Notice
S017 2016-02-16 30-day Notice
S016 2016-01-27 30-day Notice
S015 2015-10-07 30-day Notice
S014 2014-08-22 30-day Notice
S013 2014-04-04 Real-time Process
S012 2012-11-30 30-day Notice
S011 2012-09-05 30-day Notice
S010
S009 2012-02-29 30-day Notice
S008 2012-01-31 135 Review Track For 30-day Notice
S007 2011-11-21 30-day Notice
S006 2011-11-01 Normal 180 Day Track
S005 2011-08-29 135 Review Track For 30-day Notice
S004 2011-08-17 135 Review Track For 30-day Notice
S003 2011-05-17 Normal 180 Day Track No User Fee
S002 2011-04-11 30-day Notice
S001 2010-07-28 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.